What is caffeine?

Caffeine is a naturally occurring alkaloid of the methylxanthine family, produced by coffee, tea, cacao, guarana and kola nut plants. It is the world's most consumed psychoactive substance: it blocks adenosine receptors in the brain, postponing the feeling of tiredness and boosting alertness.

Chemically, caffeine is 1,3,7-trimethylxanthine (C8H10N4O2), a white, bitter, crystalline compound first isolated in 1819 by the German chemist Friedlieb Ferdinand Runge — reportedly on a request from Goethe himself. The plant synthesises it as a natural pesticide: caffeine paralyses leaf-eating insects and also inhibits the germination of rival seedlings around the coffee tree, a phenomenon ecologists call allelopathy.

The pharmacology of caffeine is now well established. Throughout the day, a molecule called adenosine accumulates in the brain and binds to its A1 and A2A receptors, slowing neuronal activity and producing drowsiness. Caffeine mimics the three-dimensional shape of adenosine closely enough to dock onto the same receptors without activating them — a classic case of competitive antagonism. Drowsiness is masked, dopamine and noradrenaline circulate more freely, and alertness climbs. The European Food Safety Authority (EFSA) considers a single dose of up to 200 mg safe for healthy adults and a total daily intake of up to 400 mg as posing no safety concern (EFSA Scientific Opinion, 2015).

Caffeine is almost fully absorbed by the small intestine within 30 to 45 minutes, peaks in the bloodstream around the 45-minute mark, and is broken down by the liver enzyme CYP1A2. The average half-life in adults is 4 to 6 hours, but individual variation is dramatic: slow metabolisers can hold caffeine twice as long as fast ones. This genetic difference is a big reason why one person shrugs off a 5 p.m. espresso while another is still wired at midnight.

How much sits in a cup depends on method and variety. A ristretto-style espresso carries roughly 63 mg, a pour-over around 95 mg, and a French press close to 107 mg (USDA FoodData Central). Arabica beans cap out around 1.2 to 1.5 % caffeine by weight, while Robusta pushes 2.2 to 2.7 %. A specialty espresso pulled in Brussels, Ghent or Antwerp with an 18 g Arabica dose typically lands between 100 and 130 mg — the same amount as the 1.5 litres of cola many office workers sip through the afternoon, delivered in one 30 ml shot.

Caffeine at a glance: key pharmacology

Caffeine's biological role and evolutionary context

Caffeine's existence in coffee plants is not incidental — it serves a specific ecological function as an insecticidal and allelopathic compound. Coffea plants produce caffeine in their leaves and unripe fruits specifically to deter insect herbivores: caffeine is toxic to most insects at the concentrations present in coffee leaves, protecting the plant from predation. The concentration decreases in ripe cherries (when seed dispersal by birds and mammals is beneficial) and is highest in young leaves and unripe fruits (when protection is most needed). This ecological logic is shared by tea, guaraná, cacao and yerba mate — all of which independently evolved caffeine biosynthesis for similar protective reasons.

The alkaloid's biosynthetic pathway in coffee has been mapped in detail: starting from xanthosine (a purine derivative), a series of four methylation steps (catalysed by N-methyltransferase enzymes) produce theobromine as an intermediate before the final N-7 methylation step produces caffeine. Understanding this pathway explains why coffees grown under high insect pressure at lower altitudes or in disrupted ecosystems might produce slightly higher caffeine concentrations than coffees grown at altitude under shade canopy — the plant modulates its chemical defense responses to local pest pressure, though the genetic baseline (set by variety) dominates over environmental modulation.

Going deeper

The discovery of caffeine as an adenosine antagonist — the mechanism behind its wakefulness-promoting effects — happened surprisingly recently in neuroscience terms. While caffeine had been consumed for its stimulant effects for centuries, the adenosine receptor system itself wasn't described until the 1970s, and caffeine's mechanism as an adenosine A1 and A2A receptor blocker wasn't fully characterised until the 1980s. Before this, caffeine's stimulant effect was attributed variously to phosphodiesterase inhibition (it does this, but at higher concentrations than typical coffee provides) and to direct central nervous system stimulation without a clear receptor mechanism. The adenosine discovery gave caffeine research a mechanistic framework that has since generated hundreds of studies on sleep, cognition, neuroprotection and cardiovascular physiology — all tracing back to one molecule's competitive antagonism at adenosine receptors.